AI – Medxy AI

Evaluating the Role of AI Tools in Pharmacy Students’ OSCE Performance and Anxiety: Insights from a Randomized Controlled Trial

By MedXY 08/27/2025

A randomized trial assessing AI-generated study materials revealed no significant impact on pharmacy students’ objective structured clinical examination scores or test anxiety levels, highlighting the need for further research on long-term educational outcomes.

AI Psychiatry Specialties

Enhancing Depression Care in College Students: AI Chatbots with Social Cues Show Superior Effectiveness

By MedXY 08/27/2025

A 16-week randomized trial demonstrates that AI chatbots with high-social-cue design significantly reduce depression and anxiety symptoms in college students compared to text-only chatbots, improving adherence, satisfaction, and therapeutic alliance.

AI Family Medicine Specialties Wellness & Lifestyle

AI Versus Family Physicians: Evaluating ChatGPT-4o’s Responses to Common Primary Care Queries

By MedXY 08/27/2025

This study compares ChatGPT-4o and family physicians in answering 200 common primary care questions, revealing AI’s superior performance in appropriateness, accuracy, comprehensiveness, and empathy, highlighting its potential in enhancing primary care.

AI Clinical Updates Psychiatry Specialties Wellness & Lifestyle

Evaluating a Proactive E-Health Intervention for Co-occurring At-Risk Alcohol Use and Depressive Symptoms: Adherence, Reach, and Two-Year Outcomes

By MedXY 08/25/2025

This RCT assessed a proactive e-health intervention for patients with at-risk alcohol use and depressive symptoms, showing high adherence but only small, non-significant improvements at 12 months and no lasting effects at 24 months.

AI Clinical Updates Neurology Pediatrics Specialties Wellness & Lifestyle

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation

By MedXY 08/24/2025

A tailored, app-supported exercise program delivered via mobile health significantly improves core ADHD symptoms and executive functions in children, demonstrating comparable effectiveness to traditional face-to-face exercise guidance.

AI Medical News Ophthalmology Specialties Wellness & Lifestyle

Japan’s Bold Move: Limiting Daily Smartphone Use to Protect Eye Health and Well-being

By MedXY 08/23/2025

Japan’s Aichi Prefecture proposes a new ordinance limiting daily smartphone use to two hours, citing research that excessive social media use causes eye fatigue and physiological distress, especially among youth.

AI General Surgery Specialties

Virtual Reality for Reducing Preoperative Anxiety: Insights from Cardiac Surgery Trials and Meta-Analyses of Elective Surgical Procedures

By MedXY 08/21/2025

Virtual reality (VR) interventions show promise in mitigating preoperative anxiety, with clinical trials and meta-analyses indicating moderate but significant anxiolytic effects across surgical populations, especially in cardiac surgery and pediatric patients.

AI Cardiology Clinical Updates Specialties

Self-Monitoring of Blood Pressure With Mobile App Feedback Enhances Control and Adherence in Uncontrolled Hypertension: Insights From the SMART-BP Trial and Broader Evidence

By MedXY 08/21/2025

The SMART-BP trial demonstrates that a mobile app providing tailored feedback significantly improves systolic blood pressure reduction and drug adherence compared to self-monitoring alone, highlighting innovative digital solutions in hypertension management.

AI Specialties

Challenges in Distinguishing Human-Authored from AI-Generated Medical Manuscripts and Personal Statements

By MedXY 08/21/2025

Recent studies reveal that human reviewers struggle to differentiate AI-generated medical documents from human-authored texts, with AI often producing higher-quality personal statements that influence evaluation outcomes.

AI OB/GYN & Women's Health Specialties Wellness & Lifestyle

Evaluating Digital Therapeutics for Midlife Women’s Menopausal Symptoms: A Synthesis of Recent Randomized Controlled Trials

By MedXY 08/20/2025

This review synthesizes evidence on mobile digital therapeutics targeting vasomotor and behavioral health symptoms in menopausal and midlife women, highlighting efficacy, engagement, and implications for scalable symptom management.

AI Psychiatry Specialties Wellness & Lifestyle

Efficacy and Safety of ALM-003 Digital Therapeutic in Alcohol Dependence: A Multicenter Open-Label Randomized Controlled Trial

By MedXY 08/20/2025

This review synthesizes evidence from a multicenter RCT showing ALM-003 digital therapeutic reduces heavy drinking days significantly in alcohol-dependent individuals at high risk, with an excellent safety profile.

AI Diabetes & Endocrinology Specialties Wellness & Lifestyle

Harnessing Digital Therapeutics to Improve Glycemic Control in Type 2 Diabetes: Insights from the BRIGHT Trial

By MedXY 08/20/2025

The BRIGHT trial evaluates AspyreRx, a digital cognitive behavioral therapy, for enhancing glycemic control in type 2 diabetes patients with residual hyperglycemia on stable medical therapy, focusing on efficacy, safety, and real-world applicability.

AI Psychiatry Public Health Specialties Wellness & Lifestyle

Digital Therapeutics in Suicide Prevention: Evidence and Clinical Implications of a Smartphone-Based CBT Intervention

By MedXY 08/20/2025

Smartphone-delivered cognitive-behavioral therapy (CBT) via a digital therapeutic app significantly reduces recurrent suicide attempts and sustains reduction in suicidal ideation among adults with prior suicide attempts.

AI Diabetes & Endocrinology Specialties Wellness & Lifestyle

Harnessing Digital Health Technologies in Obesity Management: Insights from a Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials

By MedXY 08/18/2025

Digital health interventions show modest but clinically meaningful reductions in waist circumference for overweight and obese adults, highlighting their potential as adjuncts in obesity care despite limited effects on weight and behavior.

AI Clinical Updates OB/GYN & Women's Health Oncology Radiology Specialties Wellness & Lifestyle

Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms

By MedXY 08/18/2025

A recent study shows that an AI system can detect interval breast cancers missed by radiologists on mammograms, potentially improving early diagnosis and screening outcomes in women with dense breasts.

AI Cardiology Specialties

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry

By MedXY 08/17/2025

AI-based quantitative CT analysis demonstrates that coronary plaque features, while more prevalent in men, confer a disproportionately higher relative risk of major adverse cardiovascular events in women, highlighting the need for sex-specific risk assessment and targeted interventions.

AI Clinical Updates Nephrology Specialties Wellness & Lifestyle

Evaluating Electronic Nudges to Enhance Guideline-Directed Therapy in Chronic Kidney Disease: Insights from the NUDGE-CKD Trial

By MedXY 08/16/2025

The NUDGE-CKD trial found that electronic letter-based nudges to patients with chronic kidney disease and their general practitioners did not significantly improve initiation of guideline-recommended medications over usual care.

AI Cardiology Specialties

Advancing Acute Coronary Syndrome Care: ECG-Based Machine Learning Enhances Risk Stratification

By MedXY 08/16/2025

A prospective study shows that machine learning models trained on 12-lead ECG features outperform HEART score in predicting mortality among chest pain patients, improving risk-based care precision.

AI Specialties Wellness & Lifestyle

The AI Doctor Is Out? How California’s Ab 489 Could Limit AI Development in Healthcare

By MedXY 08/15/2025

California’s AB 489 may reshape AI in healthcare, emphasizing authorized interactions and compliance for AI developers.

AI Medical News Specialties Wellness & Lifestyle

Oracle Health Launches AI-First, Voice-Enabled EHR to Enhance Clinician Experience and Compete with Epic

By MedXY 08/14/2025

Oracle Health unveils a next-generation AI-powered, voice-first electronic health record (EHR) system designed from the ground up to improve clinical workflow and challenge Epic’s market dominance in the U.S. acute care sector.